Dedicare AB

Dedicare AB

Dedicare AB

Overview
Date Founded

1995

Headquarters

Ringvägen 100,10th Floor,Stockholm 118 60

Type of Company

Public

Employees (Worldwide)

658

Industries

Hospitals & Patient Services
Human Resources & Personnel Services

Company Description

Dedicare AB engages in the provision of healthcare staffing services. It offers temporary staff recruitment of doctors, nurses, social workers, and teaching professionals. The firm operates through the Sweden and Norway geographical segments. The company was founded in October 1995 and is headquartered in Stockholm, Sweden.

Contact Data
Trying to get in touch with decision makers at Dedicare AB? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Financial Officer

Finance Director & Head-Investor Relations

Business Controller

Manager-Nurse Norway Business Area

Manager-Nurse Sweden Business Area

Board of Directors

Chief Executive Officer at Bro Hof Slott AB

Former Chief Executive Officer & MD at Poolia AB

Chief Executive Officer at Swedish Medtech Service AB

Paths to Dedicare AB
Potential Connections via
Relationship Science
You
Dedicare AB
Owners & Shareholders
Details Hidden

HP is an alternative investment manager specializing in healthcare investments. The firm invests globally in equity, their assets being almost entirely invested in the US.They follow a long/short equity strategy and may occasionally engage in shareholder activism.HP's investment process targets under-researched firms in the pharmaceutical, medical technology, biotechnology and healthcare service sectors. They favor micro-, small- and mid-cap companies. Their investment philosophy consists in leveraging their healthcare expertise to identify companies for which market value largely underestimates or overestimates intrinsic value and growth potential.HP's investment process is bottom-up and based on in-house research supplemented with input from sector specialists. The firm relies on the expertise of medical experts including academics. Non-core functions are outsourced.

Details Hidden

HP is an alternative investment manager specializing in healthcare investments. The firm invests globally in equity, their assets being almost entirely invested in the US.They follow a long/short equity strategy and may occasionally engage in shareholder activism.HP's investment process targets under-researched firms in the pharmaceutical, medical technology, biotechnology and healthcare service sectors. They favor micro-, small- and mid-cap companies. Their investment philosophy consists in leveraging their healthcare expertise to identify companies for which market value largely underestimates or overestimates intrinsic value and growth potential.HP's investment process is bottom-up and based on in-house research supplemented with input from sector specialists. The firm relies on the expertise of medical experts including academics. Non-core functions are outsourced.

Recent Transactions
Details Hidden

Humana AB purchases Dedicare Assistanse AS from Dedicare AB

Details Hidden

Alminia AB, Svensk Personlig Assistans AB purchase Dedicare Assistans AB from Dedicare AB

Clients

Capio AB engages in the provision of medical, surgical, and psychiatric healthcare services. It operates thorugh the following segments: Capio Nordic, Capio France, and Capio Germany. The Capio Nordic segment includes Capio Sweden, Capio Norway, and Capio Denmark, which consists of emergency, local, and specialist hospitals; locations for specialist, psychiatric, and primary care; and radiology centers. The Capio France segment comprises of emergency and local hospitals, specialist clinics, and day surgery center. The Capio Germany segment consists of general hospitals, specialists clinics, and outpatient clinics. The company was founded in 1994 and is headquartered in Gothenburg, Sweden.

Key Stats and Financials As of 2018
Market Capitalization
$551M
Total Enterprise Value
$404M
Earnings Per Share
$4.22
Revenue
$812M
Net Profit
$38.2M
EBITDA
$51.4M
EBITDAMargin
6.33%
Total Equity
$102M
Total Debt
$0
Five Year Compounded Annual Growth Rate Of Revenue
9.1%
Three Year Compounded Annual Growth Rate Of Revenue
12.31%
Enterprise Value Sales
0.5x
Enterprise Value EBITDAOperating
7.85x
TEVNet Income
10.56x
Debt TEV
0x
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Dedicare AB. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Dedicare AB's profile does not indicate a business or promotional relationship of any kind between RelSci and Dedicare AB.